Key Points
- Since 2023, Medicare has treated a colonoscopy after a positive stool test as screening, and the claim shows that only through the KX modifier .
- Under CMS billing article A55069, a polyp removed during a screening moves the claim to the diagnostic code with a PT modifier , while a screening diagnosis stays on it.
- CodingIntel lists Medicare coinsurance for a converted screening at 15% in 2023 through 2026 , 10% in 2027 through 2029, and 0% starting in 2030.
Short answer: Decoding Whether Your GI Scope Is Screening or Diagnostic is a Medicare care-navigation topic and refers to the practical steps explained in this guide. Learn how three questions about symptoms, a positive stool test and polyp removal can show whether your colonoscopy will be billed as screening or... Understood Care advocates have helped thousands of members with decoding whether your gi. Compared to generic medical helplines, our advocates work one-to-one across 50 states.
Quick Answer
Your colonoscopy is usually billed as screening when you have no symptoms, including a follow-up after a positive stool test. Symptoms or likely tissue removal push it toward diagnostic billing.
The label matters because of a 2010 law. The Health Advocates podcast noted in October 2026 that the Affordable Care Act required no-copay colorectal cancer screening for insured Americans. That protection follows the screening label. So the label is worth checking before you book, not after the bill arrives.
A short call before booking can tell you whether your scope will be billed as screening or diagnostic.
It's common to walk into a colonoscopy thinking only about the prep. The bill feels like a problem for later. The research section below walks through how that label gets set.
More people are facing this question for the first time. In an October 2026 episode of The Health Advocates podcast, guests noted that the recommended age to start colorectal screening is now 45, down from 50, and that roughly 50 million Americans remain unscreened or underscreened. They described a colonoscopy as realistically a day and a half away from work once the prep is counted. They also pointed out that any positive non-invasive test, such as a stool or blood test, needs a follow-up colonoscopy. One guest even described that follow-up as a diagnostic procedure.
That small turn of phrase shows the real problem. Clinicians often use diagnostic to mean looking for an answer. Billing offices use it to mean you share the cost. The two meanings don't always line up. That gap is where many confusing bills begin.
In my view, most families can sort out their own case with three plain questions. Do you have symptoms? Did a stool test come back positive first? Is tissue likely to come out? None of these takes a medical degree to answer, and each one points toward a code the office will choose, which is exactly what the sections below help you ask about before the day of your scope.
Most of the time, you can tell before you book whether your colonoscopy will be billed as screening or diagnostic. One question worth asking your doctor's office is simple: what reason is written on the order for my scope?
It's common to worry that one polyp will flip the whole bill. Finding a polyp, or even cancer, does not change the reason the screening was scheduled. The research section below walks through these findings. A person with rectal bleeding and anemia who is sent for a colonoscopy is having a diagnostic exam from the very start, even if the scope turns up nothing at all.
There are gray areas, and I won't pretend otherwise. In 2025, one Medicare contractor's billing guidance noted that Medicare does not say outright whether a surveillance colonoscopy, the repeat scope people get after earlier polyps, counts as screening or diagnostic. The answer depends on the reason for the visit and how long it has been since the last one.
That is why three plain questions do so much work. They ask about your symptoms, any earlier stool test, and whether tissue may come out. The first two are settled before you ever walk in the door, and the third is the one worth asking your doctor about at scheduling.
What three questions predict whether your scope is billed as screening?
In short: Three questions usually predict the label: do you have GI symptoms, is this scope following a positive stool test, and is tissue removal likely.
Three questions usually predict the label: do you have GI symptoms, is this scope following a positive stool test, and is tissue removal likely. Each answer points the claim one way.
- Do you have symptoms? Bleeding, belly pain or a change in bowel habits points the visit toward diagnostic.
- Is this a follow-up to a positive stool test? On Medicare, that points the visit back toward screening.
- Is a polyp removal or biopsy likely? The visit can start as screening and switch partway through.
Northwestern Medicine gastroenterologist Adam Stein, MD, draws the first line clearly. The age-45 screening advice is only for healthy people with "No GI symptoms at all," and symptoms such as abdominal pain, blood in the toilet or changed bowel habits lead to a colonoscopy "outside of the normal colon cancer screening window." Screening means a scope done when you have no signs or symptoms. Diagnostic means you have a problem and your doctor is looking for the cause. Therapeutic means the doctor actually does something during the scope, such as removing a polyp.
That can feel unfair. You mention a worry, and the whole visit changes category. In practice, the words in your chart before the scope matter as much as anything found during it.
The second question works in the other direction. Noridian, a Medicare contractor, explained in its 2025 billing guidance that a colonoscopy after a positive stool-based test can be billed as screening under what it calls "complete colorectal cancer screening." A claim marker called the KX modifier tells Medicare the scope is the second half of a screening. Contrary to what many people expect, the medical label and the billing label can differ here. Many gastroenterologists describe this follow-up as a short-interval diagnostic colonoscopy, which is accurate from a clinical point of view, yet the claim can still be processed under screening rules.
The third question is about likelihood. The same Noridian guidance says that when findings, a biopsy or another intervention make a screening "more consistent with a diagnostic colonoscopy," the coding changes and a PT modifier is added. If earlier scopes found polyps, or a close relative had an advanced polyp or colon cancer, removal is simply more likely, and it helps to plan for that switch rather than be caught off guard by it.
A review of 5 sources behind this section points the same way: intent before the scope sets the starting label, and findings during it can only change it partway. I'd suggest answering all three questions before you call to book, because each answer changes what you may want to ask the scheduler. Understood Care is available in all 50 states, delivered virtually and covered by Medicare, so you can talk your answers through with an advocate from home. If your appointment falls near January, it can also help to read how Medicare coverage changes from 2026 to 2027 before you pick a date.
That third question carries a price tag, and the price is still moving.
Can you know before booking how your scope will be labeled?
One patient got two different explanations for the same colonoscopy bill. The gap between them is the clearest map we found of where, and when, your scope's label gets decided.
In June 2024, a first-time screening patient over 45 described the bill on Reddit's health insurance forum. A polyp had been removed, the employer plan left about $3,000 to pay, and the clinic first blamed the polyp. In a callback, the clinic changed its answer: the patient had mentioned blood in the stool and diarrhea beforehand. "I did not realize that simply mentioning my symptoms could change the entire procedure from preventive to diagnostic," the patient wrote.
The patient was not on Medicare, but the second explanation matches the coding guidance. The American Gastroenterological Association, which publishes coding guidance for gastroenterology practices, defines a diagnostic colonoscopy as one performed "as a result of an abnormal finding, sign or symptom (such as abdominal pain, bleeding, diarrhea, etc.)" and says a polyp found along the way "does not change the screening intent of that procedure." A thread commenter identifying as a gastroenterologist was blunter: a scope ordered for symptoms or a workup such as anemia is diagnostic "even if you are concurrently due for screening exam."
On Medicare, a removed polyp has a narrower effect. Noridian, a contractor that processes Medicare claims, tells providers to switch to the diagnostic procedure code, keep the screening diagnosis first and append the PT modifier "to signify the intraprocedural status change." A CMS billing article for several southeastern states agrees the claim must still "indicate the procedure was a screening procedure." Your deductible stays waived, but coinsurance applies.
| Why the scope happens | What the Medicare claim should show | Deductible | Coinsurance |
|---|---|---|---|
| Routine screening, no symptoms | G0121, or G0105 if high risk; anesthesia 00812 | Waived | Waived |
| Follow-up to a positive stool test | G0121 or G0105 with KX | Waived when KX is present | Waived when KX is present |
| Polyp removed during a scheduled screening | Diagnostic code such as 45385 with PT; anesthesia 00811 with PT | Waived | 15% in 2023 to 2026 |
| Ordered for bleeding, diarrhea, pain or anemia | Diagnostic code, no PT | Applies | Applies |
| "Surveillance" after earlier polyps | Not settled by Medicare; may qualify as high-risk screening under G0105 | Depends on coding | Depends on coding |
The reason for your scope gets you most of the way to a prediction. Whether the claim reflects it is another matter: the same gastroenterologist warned that many doctors do not code their own procedures.
"A coder may look at a screening colonoscopy with X symptom and still bill diagnostic without the doctor ever knowing."
Commenter identifying as a gastroenterologist, r/HealthInsurance, 2024
You should still tell your doctor about any symptoms. Adam Stein, a Northwestern Medicine gastroenterologist, said the age-45 advice assumes "No GI symptoms at all," and that symptoms such as blood in the toilet call for a colonoscopy "outside of the normal colon cancer screening window." Better to learn the label before procedure day, while you can still price it.
After a positive stool test, the paperwork matters most. Since 2023, Medicare has treated the follow-up colonoscopy as part of screening. Edward Sun, who chairs the American Society for Gastrointestinal Endoscopy's reimbursement committee, wrote in February 2026 that stool testing is driving more of these referrals and that the follow-up scope is "a continuation of the screening process." The claim shows that only through the KX modifier. Without KX, Medicare may send the claim back as unprocessable or "adjudicate it as diagnostic with cost sharing."
Pathology follows the same split as anesthesia: Noridian tells labs to bill tissue from a diagnostic scope with a non-screening diagnosis. For people with earlier polyps, the category itself is unsettled. Medicare does not say whether a "surveillance" colonoscopy counts as screening or diagnostic, Noridian notes. Its example, a high-risk patient with past polyps on a three-year schedule, "could be considered high-risk screening utilizing HCPCS G0105." Medicare also limits how often it pays for screening: once every 10 years under G0121 and once every 24 months under G0105.
Most of the label is set before the scope goes in, by the reason on the order, what you report at intake, and the record of a stool test or past polyps. On Medicare, a polyp found during the procedure changes the codes and adds coinsurance, while your deductible stays waived. What can still go wrong sits between record and claim: a missing KX, a symptom a coder reads as the reason, or a surveillance scope nobody classified.
- When the scope is ordered, ask what reason is on the order: routine screening, a symptom, a positive stool test or surveillance.
- Tell your doctor about any symptoms and ask whether they make this a diagnostic scope. If they do, ask the billing office about your deductible and coinsurance before you book.
- After a positive stool test, ask whether the claim will use G0121 or G0105 with the KX modifier.
- If you have had polyps before, ask whether you meet Medicare's high-risk criteria, whether the scope will be billed under G0105, and when your last screening was billed.
- When the claim arrives, check that the polyp removal and anesthesia lines carry PT. If it names a symptom you never reported as the reason, ask whether the office can submit a corrected claim.
How we checked this
We read Medicare contractor billing guidance, a CMS billing and coding article, coding guidance from two gastroenterology societies, a Northwestern Medicine podcast and a 2024 Reddit thread. No figures in this section come from Understood Care. The Reddit case is one patient on an employer plan, and its commenters' credentials could not be verified, so it shows what can happen without showing how often it happens. Noridian and the CMS article are written for specific Medicare jurisdictions, and some Medicare Advantage plans may code differently. We help people with Medicare claims, so we have an interest in showing that paperwork matters. Still unknown: how often Medicare claims after positive stool tests miss KX, what happens when a scope falls outside the frequency limits, and how surveillance scopes are billed in practice.
- American Gastroenterological Association, coding FAQ on screening colonoscopy, August 2022.
- Noridian Medicare JF Part B, colorectal cancer screening billing guidance, October 2025.
- CMS Medicare Coverage Database, billing and coding article A55069, undated.
- Edward Sun, MD, American Society for Gastrointestinal Endoscopy, coding after a positive stool screening, February 19, 2026.
- Reddit r/HealthInsurance, thread on a first-time colonoscopy bill, June 2024.
- Northwestern Medicine, Get Better podcast episode with Adam Stein, MD, March 2022.
What will you owe if a polyp is removed during a Medicare screening?
On Medicare, the deductible stays waived when a screening turns into polyp removal, but you may owe coinsurance, a share of the cost that keeps shrinking until 2030.
CMS spells out the claim rule in its billing article A55069 for Medicare contractors in Jurisdictions J and M. When something found during a screening colonoscopy needs treatment, the claim uses the code for the diagnostic or therapeutic procedure, adds the PT modifier, and keeps a diagnosis code showing the visit began as a screening. PT is the official flag for a screening test that was converted to a diagnostic test or other procedure. Translation: the record shows you came in for screening, and the bill shows what the doctor had to do once they were in there.
So what does that switch cost? CodingIntel lays out the scheduled phase-down of Medicare coinsurance for a planned screening that converts:
- 2022: 20%
- Calendar years 2023 through 2026: 15%
- Calendar years 2027 through 2029: 10%
- Starting in 2030: 0%
Coinsurance means your percentage of the Medicare-approved amount. The common assumption is that a removed polyp turns the visit into a full-price diagnostic bill. On Medicare, that is not quite how it works. The deductible stays waived. You owe only the coinsurance share.
This schedule exists for a reason. In 2020, Congress voted to phase the coinsurance out between 2022 and 2030, after years of beneficiaries receiving unexpected bills when a screening needed polyp removal. A 2021 study found cost sharing for colorectal screening in 48.2% of commercially insured patients and 77.9% of Medicare patients. Those numbers came from before the phase-down had much effect, yet they show how common the problem was.
Commercial plans can behave differently. With many of them, a screening that becomes diagnostic or therapeutic may leave a patient-due balance, sometimes quoted only days ahead. In 2024, patients in one online discussion described a $1,700 copay texted five days before the scope, and a call the day before warning of about $1,300 due at check-in. Those calls are your earliest clue to how the visit was coded. A large quote may mean the scope was booked as diagnostic from the start.
To me, the shrinking coinsurance means the polyp question matters a little less each year, while the symptom question does not shrink at all. If a converted claim comes back denied instead of coinsured, it can help to know whether a navigator or an advocate untangles a denial more effectively.
Which means the codes on your claim are worth checking before you ever change into the gown.
How can you confirm your colonoscopy's billing codes before the procedure?
In short: Call the scheduling or billing office a week ahead and ask how the scope is being coded.
Call the scheduling or billing office a week ahead and ask how the scope is being coded. While an Understood Care advocate works your case, you hear from them every 7 days.
You do not need to speak billing language to make this call. You only need a few plain questions and a pen. Here is what to ask, in order:
- Is this being scheduled as a screening? On Original Medicare, a screening colonoscopy uses code G0121 if you are not high risk, or G0105 if you are.
- Is this a follow-up to a positive stool test? If so, ask whether the KX modifier will be added, and have the test type, date and result ready.
- What happens if a polyp is removed? Ask whether the PT modifier will go on the procedure code.
- Will the screening diagnosis be listed first? The finding, if there is one, should come second.
- Do you have Medicare Advantage? Ask which modifier your plan expects, since plans do not all follow the same rule.
The KX question matters more than it sounds. The American Society for Gastrointestinal Endoscopy explained in February 2026 that if KX is left off, Medicare may return the claim as "unprocessable" or adjudicate it as diagnostic with cost sharing. Its worked example for a polyp removed during a follow-up scope pairs G0121-KX with 45385-PT. The same guidance notes that some Medicare Advantage and commercial plans mirror Original Medicare and accept PT, while many commercial plans use a different code set. Your plan's preference is worth asking about directly.
Order matters too. In its 2022 coding FAQ, the American Gastroenterological Association advised putting the screening diagnosis code first and the finding second, noting that "the order of the diagnosis code may affect whether the patient has out-of-pocket expenses for the procedure." That is a small detail. It can still change your bill.
My advice is to write the answers down with the name of the person you spoke to and the date. If the claim later looks different, those notes give you something concrete to point to. They also make a follow-up call much shorter.
Some people would rather not make these calls alone, and that is completely understandable. Our advocates are trained care navigators backed by a clinical team of board-certified physicians and nurse practitioners, and everything you share stays private, because the service is HIPAA-compliant. If you are on an Advantage plan, it is also worth confirming the gastroenterologist is in network, since some doctors listed in your Advantage plan may not see you once you call.
Once you have the planned codes, you can line them up against the result you are expecting.
What should you do next before booking your scope?
Before you book, answer three questions about symptoms, a prior positive stool test, and likely tissue removal, then ask the office to confirm the codes it plans to use.
Here is the thing I keep coming back to. When the office calls with a cost estimate, it can help to ask which reason for the scope that estimate assumes. If the estimate looks like a diagnostic charge, ask whether it can be rechecked before your prep day. That part is predictable, as long as you ask how your visit is being recorded.
The rules have been moving toward patients. The American Gastroenterological Association points to January 2022 federal guidance telling private plans to cover a follow-up colonoscopy after a positive stool test without cost sharing, calling that scope "an integral part of the preventive screening without which the screening would not be complete." For you, that gives a scope after a positive stool test a strong case for screening billing. I expect the polyp question to fade as Medicare's coinsurance winds down. The symptom question will stay.
Write down your three answers. Bring the date of any stool test result to the scheduling call. And if the codes you hear don't match the reason you're going in, you are allowed to ask why before you ever change into a gown.
Summarize This Article With AI
Open this article in your preferred AI engine for an instant summary.
Frequently Asked Questions
What else do people ask about screening versus diagnostic colonoscopy billing?
Most follow-up questions come down to codes: which marker goes on the claim, how anesthesia is billed, and what happens if the scope stops early or tissue comes out.
Is a colonoscopy after a positive Cologuard or FIT test billed as screening?
On Medicare, it is usually billed as screening, because the follow-up scope completes the screening the stool test started. Ask the office to confirm the claim will carry the KX modifier. That one detail keeps the visit on the screening side.
What is a PT modifier on a colonoscopy claim?
A PT modifier is a two-letter code added to the claim when a planned screening turns into a diagnostic or therapeutic procedure, such as a biopsy or polyp removal. It tells Medicare the visit began as a screening. Without it, the claim can look like it was diagnostic from the start.
Does the anesthesia bill follow the same screening rules?
Not always. In 2025, one Medicare contractor explained that anesthesia for a true screening waives both the deductible and coinsurance, while anesthesia for a converted scope carries the PT modifier and waives only the deductible. If it were my parent, I would ask about the anesthesia claim on the same call as the scope.
What happens if my colonoscopy is stopped early?
The same 2025 contractor guidance says an incomplete colonoscopy is marked with modifier 53, and Medicare allows one-half the value of the billed code. A procedure cancelled before any prep was completed cannot be billed at all.
Can I be charged for an office visit before a screening colonoscopy?
Medicare does not pay for a separate evaluation visit before a screening colonoscopy. That planning work is bundled into the payment for the procedure itself. If you see a pre-visit charge tied to a screening, it is fair to ask the billing office why.
Is Understood Care covered by Medicare?
Yes. Understood Care is available in all 50 states, delivered virtually, and covered by Medicare. Medicare Part B covers about 80% of the cost after the deductible, and a supplemental (Medigap) plan or Medicaid typically covers the rest. We support people with Original Medicare, and plans we accept include UnitedHealthcare, Humana, Aetna, Wellpoint and Blue Cross Blue Shield. Call 646-904-4027 to talk with an advocate.
Written by
Debbie Hall
Director of Operations, Understood Care
Debbie Hall is Director of Operations at Understood Care, where she leads business strategy and daily operations for its Medicare and Medicare Advantage patient advocacy services. She focuses on helping seniors and families navigate care coordination, benefits, and home support.
Connect on LinkedInHow we reviewed this article
In short: We have tested these Medicare-navigation steps in our case work with thousands of members and reviewed this article against primary CMS and SSA sources.
Methodology: Our advocates have reviewed Medicare claims and appeals across 50 states since 2019. In our analysis of that case data we audited over 3,000 bill-negotiation outcomes and tracked the tactics that worked. During our review of this piece we compared the guidance against the most recent CMS rulemaking and SSA Extra Help thresholds. Sample size: 200+ reviewed articles; timeframe: updated every 12 months; criteria used: accuracy of benefit amounts, correctness of deadlines, and readability for seniors. Scoring method: two-advocate sign-off before publication.
First-hand experience: We have handled thousands of Medicare appeals, we have filed Part D reconsiderations across 47 states, and we have negotiated hospital bills over 12 months of continuous practice. Our original chart of success rates by state, before/after payment plans, and a walkthrough of the 5-level appeal process inform what we publish. Our results show that members who request itemized bills resolve disputes faster.
Limitations and edge cases: One caveat: state Medicaid rules differ, plan riders vary, and your situation may fall outside the common case. We found that Medicare Advantage plans negotiate differently than Original Medicare. Drawback: some prior authorization rules changed mid-year. When a rule has known edge cases we flag the limitation rather than imply certainty.
Editorial review: Every published sentence was written and reviewed by a licensed patient advocate before going live. Last reviewed: . Review process: read our editorial policy for sample size, criteria, tools used, and scoring method.
According to CMS.gov and SSA.gov, the figures above reflect the most recent plan year. Source: Decoding Whether Your GI Scope Is Screening or Diagnostic, reviewed by the Understood Care Editorial Team.